Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study

MLA

Boccara, Franck, et al. Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3710..a8b093a78e25b4b00f7d121ce53f827e&authtype=sso&custid=ns315887.

APA

Boccara, F., Kumar, P. N., Caramelli, B., Calmy, A., López, J. A. G., Bray, S., Cyrille, M., Rosenson, Robert, S. B. I. D. B., Mark, B., Robert, F., Jennifer, H., Kenneth, K., Norman, R., Stephane De Wit, Eric, F., Linos, V., Bruno, C., Jose Valdez Ramalho Madruga, … Paul. (2020). Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study.

Chicago

Boccara, Franck, Princy N Kumar, Bruno Caramelli, Alexandra Calmy, J Antonio G López, Sarah Bray, Marcoli Cyrille, et al. 2020. “Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3710..a8b093a78e25b4b00f7d121ce53f827e&authtype=sso&custid=ns315887.